Anna Saborowski

4.5k total citations · 1 hit paper
57 papers, 2.5k citations indexed

About

Anna Saborowski is a scholar working on Surgery, Oncology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Anna Saborowski has authored 57 papers receiving a total of 2.5k indexed citations (citations by other indexed papers that have themselves been cited), including 26 papers in Surgery, 23 papers in Oncology and 17 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Anna Saborowski's work include Cholangiocarcinoma and Gallbladder Cancer Studies (24 papers), Hepatocellular Carcinoma Treatment and Prognosis (13 papers) and Gallbladder and Bile Duct Disorders (11 papers). Anna Saborowski is often cited by papers focused on Cholangiocarcinoma and Gallbladder Cancer Studies (24 papers), Hepatocellular Carcinoma Treatment and Prognosis (13 papers) and Gallbladder and Bile Duct Disorders (11 papers). Anna Saborowski collaborates with scholars based in Germany, United States and Canada. Anna Saborowski's co-authors include Arndt Vogel, Gonzalo Sapisochín, Tim Meyer, Riad Salem, Arndt Vogel, Scott W. Lowe, Michael Saborowski, Oreste Segatto, Monika A. Davare and Brian Druker and has published in prestigious journals such as Proceedings of the National Academy of Sciences, The Lancet and Journal of Clinical Oncology.

In The Last Decade

Anna Saborowski

52 papers receiving 2.4k citations

Hit Papers

Hepatocellular carcinoma 2022 2026 2023 2024 2022 400 800 1.2k
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Hepatocellular carcinoma
    2022 1.3k citations Gonzalo Sapisochín, Anna Saborowski et al. profile →

Author Peers

Peers are selected by citation overlap in the author's most active subfields. citations · hero ref

Author Last Decade Papers Cites
Anna Saborowski 1.0k 770 711 579 535 57 2.5k
Robert Montal 817 0.8× 614 0.8× 921 1.3× 682 1.2× 527 1.0× 19 2.2k
Ao Huang 725 0.7× 574 0.7× 572 0.8× 787 1.4× 479 0.9× 51 1.9k
Chunyi Hao 724 0.7× 871 1.1× 403 0.6× 330 0.6× 493 0.9× 135 2.1k
Roberta Pang 1.6k 1.5× 1.1k 1.4× 815 1.1× 987 1.7× 288 0.5× 53 3.0k
Atsushi Kudo 725 0.7× 1.0k 1.4× 639 0.9× 474 0.8× 414 0.8× 129 2.4k
Philippa Newell 1.5k 1.5× 902 1.2× 1.2k 1.8× 916 1.6× 557 1.0× 16 3.3k
Paolo Abada 602 0.6× 652 0.8× 1.2k 1.7× 538 0.9× 374 0.7× 63 2.3k
Francesco Dituri 1.4k 1.4× 788 1.0× 474 0.7× 692 1.2× 272 0.5× 62 2.5k
Dean Wilkie 1.2k 1.2× 705 0.9× 620 0.9× 560 1.0× 376 0.7× 16 2.5k
Lila Adnane 1.1k 1.1× 1.0k 1.3× 659 0.9× 440 0.8× 582 1.1× 7 2.6k

Countries citing papers authored by Anna Saborowski

Since Specialization
Citations

This map shows the geographic impact of Anna Saborowski's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Anna Saborowski with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Anna Saborowski more than expected).

Fields of papers citing papers by Anna Saborowski

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Anna Saborowski. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Anna Saborowski. The network helps show where Anna Saborowski may publish in the future.

Co-authorship network of co-authors of Anna Saborowski

This figure shows the co-authorship network connecting the top 25 collaborators of Anna Saborowski. A scholar is included among the top collaborators of Anna Saborowski based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Anna Saborowski. Anna Saborowski is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Vogel, Arndt, Anna Saborowski, Lorenza Rimassa, & Anthony B. El-Khoueiry. (2025). Navigating second-line therapy after immunotherapy in advanced HCC☆. JHEP Reports. 8(1). 101630–101630. 1 indexed citations
2.
3.
Wang, Xin, Anna Saborowski, Gonzalo Sapisochín, & Arndt Vogel. (2025). Finding the Right Partner: Triplet Therapy for First-Line Advanced Biliary Tract Cancers. Journal of Clinical Oncology. 43(5). 492–497. 2 indexed citations
4.
Li, Zhihao, Daniel Aliseda, Owen Jones, et al.. (2024). Recent advances in systemic therapy for advanced biliary tract cancer: A systematic review and meta-analysis using reconstructed RCT survival data. JHEP Reports. 7(3). 101290–101290. 3 indexed citations
5.
Quante, Michael, Anna Saborowski, & C. Benedikt Westphalen. (2024). Improving gastrointestinal cancer therapy by uniting stakeholders. SHILAP Revista de lepidopterología. 3. 100040–100040. 1 indexed citations
6.
7.
Vogel, Arndt, Karthikeyan Murugesan, Júlia C.F. Quintanilha, et al.. (2024). Association of RNF43 Genetic Alterations With BRAFV600E and MSIhigh in Colorectal Cancer. JCO Precision Oncology. 8(8). e2300411–e2300411. 2 indexed citations
8.
Ziegler, Paul K., Anna Saborowski, Henning Reis, et al.. (2024). Die Modelltransferierbarkeit von KI in der digitalen Pathologie. PubMed. 45(2). 124–132.
9.
Vogel, Arndt, Oliver Waidmann, Tobias Müller, et al.. (2023). IMMULAB: A phase II trial of immunotherapy with pembrolizumab in combination with local ablation for patients with early-stage hepatocellular carcinoma (HCC).. Journal of Clinical Oncology. 41(4_suppl). 555–555. 4 indexed citations
10.
Vogel, Arndt, Anna Saborowski, Gabriele Margareta Siegler, et al.. (2023). 955P IMMUNIB trial (AIO-HEP-0218/ass): A single-arm phase II study evaluating safety and efficacy of immunotherapy with nivolumab in combination with lenvatinib in advanced hepatocellular carcinoma. Annals of Oncology. 34. S598–S598. 1 indexed citations
11.
Murugesan, Karthikeyan, et al.. (2022). Charting co-mutation patterns associated with actionable drivers in intrahepatic cholangiocarcinoma. Journal of Hepatology. 78(3). 614–626. 81 indexed citations
12.
Vogel, Arndt, Sebastian Ochsenreither, Jonathan S. Zager, Frank Wacker, & Anna Saborowski. (2022). Chemosaturation for primary and secondary liver malignancies: A comprehensive update of current evidence. Cancer Treatment Reviews. 113. 102501–102501. 4 indexed citations
13.
Marhenke, Silke, Diana Becker, Tanja Poth, et al.. (2021). The Co‐mutational Spectrum Determines the Therapeutic Response in Murine FGFR2 Fusion‐Driven Cholangiocarcinoma. Hepatology. 74(3). 1357–1370. 14 indexed citations
14.
15.
Vogel, Arndt & Anna Saborowski. (2021). Current and Future Systemic Therapies in Biliary Tract Cancer. Visceral Medicine. 37(1). 32–38. 10 indexed citations
16.
Erice, Oihane, Adrián Vallejo, Mariano Ponz‐Sarvisé, et al.. (2019). Genetic Mouse Models as In Vivo Tools for Cholangiocarcinoma Research. Cancers. 11(12). 1868–1868. 6 indexed citations
17.
Marquardt, Jens U., Anna Saborowski, Carolin Czauderna, & Arndt Vogel. (2019). The Changing Landscape of Systemic Treatment of Advanced Hepatocellular Carcinoma: New Targeted Agents and Immunotherapies. Targeted Oncology. 14(2). 115–123. 21 indexed citations
18.
Vogel, Arndt & Anna Saborowski. (2019). Current strategies for the treatment of intermediate and advanced hepatocellular carcinoma. Cancer Treatment Reviews. 82. 101946–101946. 105 indexed citations
19.
Lito, Piro, Anna Saborowski, Jingyin Yue, et al.. (2014). Disruption of CRAF-Mediated MEK Activation Is Required for Effective MEK Inhibition in KRAS Mutant Tumors. Cancer Cell. 25(5). 697–710. 222 indexed citations
20.
Sauter, Cornelia, Anna Saborowski, & H.M. Ockenfels. (2006). Unilaterale akrale Nekrosen als Abortivform einer palmoplantaren Erythrodysästhesie. Der Hautarzt. 58(7). 619–622. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Robert Montal Breakdown of academic impact, for papers by Ao Huang Breakdown of academic impact, for papers by Chunyi Hao Breakdown of academic impact, for papers by Roberta Pang Breakdown of academic impact, for papers by Atsushi Kudo Breakdown of academic impact, for papers by Philippa Newell Breakdown of academic impact, for papers by Paolo Abada Breakdown of academic impact, for papers by Francesco Dituri Breakdown of academic impact, for papers by Dean Wilkie Breakdown of academic impact, for papers by Lila Adnane
Rankless by CCL
2026